Drug therapy for urinary incontinence
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 14 (2) , 291-313
- https://doi.org/10.1053/beog.1999.0075
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of TolterodineBasic & Clinical Pharmacology & Toxicology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Efficacy of estrogen supplementation in the treatment of urinary incontinenceObstetrics & Gynecology, 1996
- Trospium chloride versus oxybutynin: a randomized, double‐blind, multicentre trial in the treatment of detrusor hyper‐reflexiaBritish Journal of Urology, 1995
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995
- Intravesical capsaicin for neurogenic bladder dysfunctionThe Lancet, 1992
- Clinical Pharmacology of Potassium Channel OpenersBasic & Clinical Pharmacology & Toxicology, 1992
- Effect of Combined Treatment with Phenylpropanolamine and Estriol, Compared with Estriol Treatment Alone, in Postmenopausal Women with Stress Urinary IncontinenceGynecologic and Obstetric Investigation, 1990
- Dose Titration in Clinical TrialsBritish Journal of Urology, 1986
- The Effect of Ubretid on Bladder Function after Recent Complete Spinal Cord InjuryBritish Journal of Urology, 1974